Tirzepatide and nose bleeds: what's actually going on

Step 1: Check whether tirzepatide is actually the likely cause

The first practical question is whether the nose bleed is plausibly related to the medicine at all. Epistaxis (the clinical term) is common in the general population, dry air, minor trauma, seasonal rhinitis and high blood pressure each account for far more episodes than any prescription treatment. The NHS medicines page for tirzepatide lists the known side effects in plain language, and nose bleeds do not feature among them. The medicine's dual GIP and GLP-1 receptor action works on appetite signalling and gastric emptying; there is no described pathway through which it would directly affect nasal blood vessels.

A common misconception is that any symptom that appears during treatment must be caused by treatment. Timing and causation are different things, and most people starting tirzepatide are also making lifestyle changes (eating differently, sleeping differently, sometimes travelling or managing stress) all of which can independently affect things like blood pressure and mucosal hydration. That does not mean you should dismiss an unexpected symptom, only that the investigation should be honest about the range of causes.

Our dedicated page on Mounjaro and nose bleeds looks at this question in more clinical depth, including the specific pharmacology involved.

Step 2: Consider the indirect routes that tirzepatide could play a part

There is one plausible indirect chain worth knowing. Nausea, vomiting and diarrhoea are among the most reported effects of tirzepatide, particularly during dose escalation. Significant or prolonged GI symptoms can cause dehydration. Dehydration thins and dries out the mucous membranes lining the nasal passages, making the small blood vessels there more fragile and more prone to breaking, especially in centrally heated or air-conditioned environments, or through winter months. This is not a direct pharmacological effect of tirzepatide on the nose; it is a secondary consequence of the body losing fluid.

The MHRA also highlighted in a January 2026 Drug Safety Update that GI symptoms from GLP-1 medicines can, if severe, contribute to dehydration and secondary effects including kidney strain, a reminder that managing those symptoms actively matters. Staying well hydrated while on tirzepatide is genuinely important, and if your GI symptoms are significant, that conversation belongs with your prescriber rather than being managed silently.

Blood pressure is another variable to track. Tirzepatide is sometimes used alongside antihypertensive medicines, and blood pressure itself fluctuates during weight-loss treatment. Uncontrolled hypertension is an independent cause of epistaxis; if you have not had your blood pressure checked recently, that is worth doing.

Step 3: Know when to act, and how

Most nose bleeds resolve within 10 to 20 minutes with basic first aid: sitting forward, pinching the soft part of the nose, breathing through the mouth. A single, brief, easily stopped nose bleed during tirzepatide treatment does not on its own indicate a problem with the medicine.

You should seek prompt medical attention if: nose bleeds are recurring or lasting longer than 20 minutes; you are losing a large volume of blood; you are taking anticoagulant medicines (blood thinners) alongside tirzepatide; or you have any associated symptoms such as severe headache, vision changes or significant dizziness. If you want a fuller picture of the patterns and triggers that are worth recognising, our page on Mounjaro nosebleeds covers what to watch for and when those patterns become worth acting on. These could point to blood pressure issues or other conditions that need assessment in their own right.

If you believe tirzepatide or any medicine has caused an unexpected symptom, the right route is to report it to the MHRA via Yellow Card. Yellow Card reports from patients contribute directly to the UK's post-marketing safety monitoring of medicines with Black Triangle status, which tirzepatide currently holds. Your report matters even if the link turns out to be coincidental.

You can also explore the broader question of whether Mounjaro affects bleeding more generally, or raise concerns through our aftercare team, who are available seven days a week.

Step 4: Raising it with a prescriber who knows your case

Tirzepatide is a prescription-only medicine, and its ongoing suitability is reviewed before every repeat at nume. That review is done by a real clinician (a named, GPhC-registered prescriber reads your case) not automated software making a blanket decision. If something is happening that feels out of place, that is exactly what the repeat review process is for.

For people thinking about starting treatment and wondering what to expect symptom-by-symptom, a broader look at how weight-loss treatment works can put the overall picture in perspective. And if you're already on tirzepatide from another provider and want to continue under properly supervised care, our Mounjaro page explains how transfer patients are handled. For anyone assessing the cost context of private tirzepatide treatment in the UK, the Mounjaro price comparison page sets out what legitimate private prescriptions typically include.

If after reading all of this you still have a specific concern about a symptom, the most useful next step is a proper clinical conversation. Our prescribers are the right people to speak to.